StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58−0.02 (-3.83%)

Close on Nov 17, 2026Market cap $13.52MP/E –Yield –

Genenta Science S.p.A. operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -€6.87M. The highest annual figure on record is -€2.49M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€6.87M–
FY2024Dec 31, 2024-€6.24M–
FY2023Dec 31, 2023-€11.21M–
FY2022Dec 31, 2022-€7.42M–
FY2021Dec 31, 2021-€6.96M–
FY2020Dec 31, 2020-€6.04M–
FY2019Dec 31, 2019-€2.49M–

More Genenta Science S.p.A. figures

See a number that looks wrong?